Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated to v3.4.2 (replacing v3.4.1); no study details, eligibility criteria, results, or other core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed. This is a minor frontend labeling change with no impact on study details.SummaryDifference0.1%

- Check27 days agoChange DetectedUI text updates include adding a 'Show glossary' option and a new 'Revision: v3.4.0' tag, plus minor capitalization changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while the older phrasing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now displays Last Update Posted and Revision: v3.3.4, and Last Update Posted (Estimated) and Revision: v3.3.3 were removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Study Results section with voluntary publications describing the trial outcomes. Updated metadata to include Last Update Posted (Estimated) and Revision: v3.3.3.SummaryDifference0.6%

- Check85 days agoChange DetectedThe page shows a new revision label: v3.3.2, replacing v3.3.1; there are no visible changes to core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.